Document:

<PAGE>

                                   DLB SYSTEMS
                         PROFESSIONAL SERVICES AGREEMENT

                                                    Agreement Date:_July 31,1999

         FOR AND IN CONSIDERATION of the mutual benefits accruing and expected
to accrue hereunder, DLB Systems, (a business unit of Premier Research
Worldwide, Ltd., a Delaware corporation) with principal offices at 1200 Route 22
East, Bridgewater, New Jersey 08807 (hereinafter referred to as "DLB"), and
Breast Cancer International Research Group, with principal offices in Edmonton,
Alberta, Canada (hereinafter referred to as "Customer"), intending to be legally
bound, hereby enter into this Professional Services Agreement (the "Agreement"):

WHEREAS, DLB employs personnel ("Employees") who possess the skills to provide
professional services and deliverables (collectively "Services") commonly
defined in the computer industry to include, without limitation, consulting,
education, installation, data entry and conversion, training, error correction
and software modifications to address the general needs and requirements
expressed by DLB's clients; and

WHEREAS, DLB often contracts to provide its clients with theses Services; and

WHEREAS, Client wishes to secure Services from DLB from time to time for one or
more engagements, each of which be set forth in a separate Work Order or
Engagement Letter the form for which is attached as Schedule A; and

WHEREAS, DLB desires to provide the Services as required by Client from time to
time in accordance with the terms and conditions set forth hereinafter.

NOW, THEREFORE, DLB and Client, intending to be legally bound, hereby agree as
follows:

1. SERVICES
   Client authorizes DLB to provide Services from time to time in accordance
   with the specific provisions designated in a Work Order or Engagement Letter
   signed by authorized officers of DLB and Client. Each Work Order or
   Engagement Letter shall incorporate the terms of this Agreement and will
   constitute a separate agreement binding upon the parties. However, in the
   event of any conflict between this Agreement and the Work Order or Engagement

Confidential                       Page 1
<PAGE>

   Letter, the provisions of the Work Order or Engagement Letter shall prevail.

2. TERM OF AGREEMENT
   2.1  This Agreement shall commence on the date it has been executed by both
        parties and shall continue until terminated in accordance with Paragraph
        6, "Default and Termination".

3. PROFESSIONAL SERVICES

   3.1  If the Work Order or Engagement Letter provides for a fixed amount of
        time, once the number of days or hours allocated to a particular Work
        Order or Engagement Letter has been used, Customer must sign a new Work
        Order or Engagement Letter within ten (10) business days or DLB reserves
        the right to discontinue working on the project. If no new Work Order or
        Engagement Letter is signed, the Customer is responsible for the ten-
        (10) additional day's work.

   3.2  DLB will expend reasonable efforts in the performance of the
        Professional Services specified in each Work Order or Engagement Letter
        and represents that its Professional Services hereunder will be of
        professional quality conforming to generally accepted industry
        standards. If necessary, DLB will engage subcontractors to assist in
        performing the Professional Services.

   3.3  Customer must promptly notify DLB if there is a justifiable problem with
        a person assigned by DLB to the Customer's project, or the work being
        performed is not justifiably satisfactory.

   3.4  Ownership of work produced under a Work Order or Engagement Letter shall
        be set forth in the specified Work Order or Engagement Letter. If no
        such designation is made, ownership of the work produced under a Work
        Order or Engagement Letter shall remain with DLB.

<PAGE>

   3.5  Customer shall provide DLB's employees with adequate work areas, access
        to computer terminals, data, software and personnel. And all other
        reasonable facilities as may be required for performance of the
        Professional Services set forth in the Work Order or Engagement Letter.

   3.6  DLB shall be paid monthly for Professional Services rendered under a
        Work Order or Engagement Letter. Charges will be based upon the fees
        agreed to in the Work Order or Engagement Letter and any amendments or
        additions thereto, which have been agreed to by both parties.

   3.7  If no Work Order or Engagement Letter is in place and the Services are
        verbally requested by Customer, then Services will be at a rate verbally
        agreed to by the parties, or if no rate has been verbally agreed to
        between the parties, DLB's standard rates for such Professional
        Services. Payment of invoices produced for Professional Services work
        performed under a verbal agreement shall be considered agreement on the
        part of Customer as to the existence of the verbal agreement.

   3.8  DLB will be reimbursed for all reasonable out of pocket expenses
        incurred and travel time, whether or not these are specifically stated
        on a Work Order or Engagement Letter.

   3.9  DLB and Customer are independent contractors and no employment, agency,
        association, partnership, joint venture or relationship,

Confidential                       Page 2
<PAGE>

        inconsistent with that of an independent contractor shall be created by
        performance of the Professional Services specified in a Work Order or
        Engagement Letter.

   3.10 Upon termination of a Work Order or Engagement Letter by either party,
        DLB shall be paid for all undisputed Professional Services rendered to
        the date of termination.

4. FEES
   4.1  Payment shall be made in accordance with the payment schedule attached
        to a Work Order or Engagement Letter. Invoices are payable within thirty
        (30) days of invoice.

   4.2  After thirty (30) days from the date of invoice, unpaid invoices are
        subject to a late payment charge of one and one half percent (1.5%) per
        month, or the highest legal rate, if less.

   4.3  All amounts mentioned in this Agreement are payable in US dollars. All
        taxable charges, if any, referred to in this Agreement and payable under
        any Work Order or Engagement Letter are net of any applicable sales,
        use, property and other taxes and import or other duties, however
        designated or levied. Payment of all such taxes and duties (excluding
        taxes assessed upon the profit or gain of DLB) shall be the sole
        responsibility of Customer.

5. CONFIDENTIALITY;
   DLB PROPRIETARY RIGHTS
   5.1  Each party agrees to keep confidential all technical, product, business,
        financial and other information regarding the business of the other
        party ("Confidential Information").

<PAGE>

   5.2  Each party shall at times protect and safeguard the Confidential
        Information of the other and shall not disclose, give, transmit or
        otherwise convey any Confidential Information, in whole or in part, to
        any third party.

   5.3  Confidential Information will not include information that (1) is or
        becomes generally known or available through no fault of the recipient;
        (2) is known to the recipient at the time of its receipt from the
        disclosing party; (3) the disclosing party provides to a third party
        without restriction on disclosure; (4) is subsequently rightfully
        provided to the recipient by a third party without restriction on
        disclosure; (5) is independently developed by the recipient, without
        reference to the disclosing party's Confidential Information; (6) is
        required to be disclosed pursuant to a governmental agency or court
        subpoena, provided the recipient promptly notifies the disclosing party
        of such subpoena to allow it reasonable time to seek a protective order
        or other appropriate relief; or (7) is approved for release by written
        authorization of the disclosing party.

   5.4  Because of the unique nature of the Confidential Information, each party
        agrees that the disclosing party may suffer irreparable harm in the
        event the recipient fails to comply with its obligations under this
        Section, and that monetary damages will be inadequate to compensate the
        disclosing party for such breach. Accordingly, the recipient agrees that
        the disclosing party will, in addition to any other remedies available
        to it at law or in equity, be

Confidential                       Page 3
<PAGE>

        entitled to seek injunctive relief to enforce the terms if this Section.

6. DEFAULT AND TERMINATION
   6.1  DLB may terminate this Agreement and any Work Order or Engagement Letter
        under it, if one or more of the following occur; 1) upon fifteen (15)
        days prior written notice, if Customer breaches the provisions of
        Section 5; 2) upon thirty (30) days written notice, if Customer shall
        fail to pay any fee for the work set forth under this Agreement or any
        current or future Work Order or Engagement Letter to it, when due, but
        such termination shall not take effect if Customer makes such payment
        prior to the expiration of the notice period; 3) upon thirty (30) days
        written notice, if Customer is in material default of any other
        provision of this Agreement, but such termination shall not take effect
        if Customer shall cure such default prior to the expiration of the
        notice period; or 4) immediately, if Customer enters into liquidation,
        whether voluntarily or compulsory, or compounds with its creditors, or
        has a receiver appointed, or commits an act of bankruptcy, or becomes
        insolvent, or enters into any arrangement with its creditors, or takes
        or suffers any similar action in consequence of debt, or ceases or
        threatens to cease to carry on business.

   6.2  Customer may terminate this Agreement and any Work Order or engagement
        Letter under it, if one or more of the following occur; 1) upon thirty
        (30) days written notice, if DLB is in material default of any provision
        of this Agreement, but such termination shall not take effect if DLB
        shall cure such default prior to the expiration of the notice period; or
        2) immediately following written notice, if DLB enters into liquidation,
        whether voluntarily or compulsory, or compounds with its creditors, or
        has a receiver appointed, or commits an act of bankruptcy, or becomes
        insolvent, or enters into any arrangement with its creditors, or takes
        or suffers any similar action in consequence of debt, or ceases or
        threatens to cease to carry on business.

<PAGE>

   6.3  Termination shall be without prejudice to the right of DLB to retain any
        fees paid before termination; to be paid any fees or charges that were
        due and unpaid or not yet invoiced at the effective date of termination;
        or seek equitable relief, damages, or both, for breach of any provision
        hereof.

7. LIMITATION OF LIABILITY
   7.1  IN NO EVENT WILL DLB BE LIABLE TO CUSTOMER OR ANY OTHER PARTY FOR ANY
        REASON WHATSOEVER, WHETHER IN CONTRACT OR TORT, FOR ANY FORM OF
        INDIRECT, SPECIAL, CONSEQUENTIAL, OR INCIDENTAL LOSS, DAMAGE OR EXPENSE
        (INCLUDING, BUT NOT LIMITED TO, LOSS DUE TO INABILITY TO OBTAIN DATA,
        LOSS OF BUSINESS, OR LOSS OF ANTICIPATED PROFITS) IN CONNECTION WITH OR
        ARISING OUT OF THE FURNISHING OF THE PROFESSIONAL SERVICES OR THE
        FUNCTIONING OR USE OF ANY SOFTWARE OR WORK PRODUCED UNDER THIS AGREEMENT
        OR ANY WORK ORDER OR ENGAGEMENT LETTER ENTERED INTO

Confidential                       Page 4
<PAGE>

        PURSUANT TO IT, EVEN IF ADVISED OF THE POSSIBILITY THEREOF.

   7.2  DLB INDEMNIFIES CUSTOMER FROM LIABILITY FOR PERSONAL INJURY OR PROPERTY
        DAMAGE CAUSED SOLELY BY DLB'S NEGLIGENCE OR WILLFUL MISCONDUCT WHILE
        PERFORMING OBLIGATIONS PURSUANT TO THIS AGREEMENT.

   7.3  IN ANY EVENT, DLB'S LIABILITY FOR DAMAGES SHALL NOT EXCEED THE PRICE
        PAID BY CUSTOMER FOR THE PARTICULAR WORK ORDER OR ENGAGEMENT LETTER
        UNDER WHICH DLB'S LIABILITY ARISES.

8. ASSIGNMENT
   Neither this agreement nor any Work Order or Engagement Letter issued under
   it shall be transferred or assigned, in whole or in part, by Customer without
   the prior written consent of DLB. In the event of a sale of all or
   substantially all of the assets of Customer, a merger, acquisition,
   reorganization or other transaction which involves a change in control of
   Customer or any part of Customer, this Agreement may be assigned to the party
   acquiring control of Customer's assets as long as the new party is not a
   direct competitor of DLB (in which case Customer must obtain DLB's written
   consent) and the new party agrees in writing to be bound by the terms and
   conditions of this Agreement and any Work Order or Engagement Letter under
   it;provided, no such consent shall be required if the new party is an
   affiliate or subsidiary who's stock is at least fifty-one (51%) owned by
   Customer. Customer shall notify DLB of any such transaction within five (5)
   business days after its occurrence.

<PAGE>

9.  NON-SOLICITATION AND HIRING OF EMPLOYEES
    Neither party shall knowingly solicit for employment, hire or utilize the
    services of any employee, agent, representative or consultation of the other
    party during the term of this Agreement or of any Work Order or Engagement
    Letter under it, or for one year after the completion of the performance of
    services hereunder, or assist any third party in so doing.

10. GENERAL
    10.1  Law to be Applied - This Agreement and all Work Orders and Engagement
          Letters under it shall be governed by and interpreted under the laws
          of the State of Delaware.

    10.2  Customer acknowledges and accepts that the role of DLB is solely that
          of a supplier of the Professional Services to be provided under this
          Agreement and any Work Orders or Engagement Letters to it.

    10.3  Publicity - The parties may collaborate on publicity, advertising,
          brochures, literature and the like as regards this Agreement and their
          business relationship. Prior to any distribution, both parties will
          approve all such material in writing.

    10.4  Notices - Notices under this Agreement, any Work Order, Engagement
          Letter or Amendment shall be deemed given when sent one (1) day after
          being presented to Federal Express or the equivalent for delivery to a
          party at the addresses specified below or such new address as either
          party shall communicate to the other in writing from time to time.

Confidential                       Page 5
<PAGE>
         To Customer:
         Breast Cancer International
           Research Group
         Edmonton, Alberta, Canada

         ATTN:

         To DLB Systems:
         DLB Systems
         1200 Route 22 East
         Bridgewater, New Jersey 08807
         ATTN:

    10.5  Force Majeure - No party to this Agreement or any Work Order or
          Engagement Letter under it shall be liable for delay or failure in the
          performance of its contractual obligations arising from any one or
          more events which are beyond its reasonable control. Upon such delay
          or failure affecting one party, that party shall notify the other
          party and use all reasonable endeavors to cure or alleviate the cause
          of such delay or failure with a view to resuming performance of its
          contractual obligations as soon as practicable.

    10.6  Waiver - The failure of any party to enforce or exercise, at any time
          or for any period of time, any term of or any right arising pursuant
          to this Agreement or any Work Order or Engagement Letter under it,
          does not constitute and shall not be construed as, a waiver of such
          term or right and shall in no way affect that party's right to later
          enforce or exercise it. The waiver by either party of the breach of
          any provision of this Agreement shall not constitute a waiver of the
          breach of any other provision or of the subsequent breach of the same
          or any other provision.

<PAGE>

    10.7  Severability - The invalidity or unenforceability of any term of or
          any right arising pursuant to this Agreement or any Work Order or
          Engagement Letter shall in no way affect the remaining terms or
          rights.

    10.8  Binding Effect - This Agreement shall be binding upon and ensure to
          the benefit of the parties, and their heirs, successors and assigns.

    10.9  Inconsistencies Between Agreement, Work Order or Engagement Letter and
          other Documents - Unless a Work Order or Engagement Letter expressly
          provides otherwise, in the event of any inconsistency between the
          terms of this Agreement and any Work Order or Engagement Letter, the
          terms of the most recent Work Order or Engagement Letter shall govern
          and control for the work specified under that specific Work Order or
          Engagement Letter. This Agreement and any Work Order or Engagement
          Letter shall govern and control in the case of any inconsistency
          between it and any purchase order, confirmation or other document
          issued by either party.

    10.10 Plural and Singular Usage - As used herein, the singular of any term
          includes the plural and the plural means the singular, whenever the
          context so requires.

    10.11 Headings - The section headings in this Agreement are inserted for
          convenience only and are not intended to affect the meaning or
          interpretation of this Agreement.

Confidential                       Page 6
<PAGE>

    10.12 Notwithstanding the general rules of construction, both DLB and
          Customer acknowledge that both parties were given an equal opportunity
          to negotiate the terms and conditions contained in this Agreement and
          agree that the identity of the drafter of this Agreement is not
          relevant to any interpretation of the terms and conditions of this
          Agreement.

    10.13 Amendment - This Agreement and its terms may not be modified, amended,
          waived, or superceded except by a written instrument signed by an
          authorized representative for DLB and an authorized representative of
          the Customer.

    10.14 The entire understanding between the parties is contained in this
          Agreement and all Work Orders and Engagement Letters under it. This
          Agreement and all Work Orders and Engagement Letters under it
          supersede all prior agreements, statements, representations,
          understandings and negotiations, whether written or oral, and in all
          cases takes precedence.

DLB SYSTEMS:
                                   Breast Cancer International Research Group:
/s/ John Bauer                     /s/ T. Saxton                /s/H.Rhouri
------------------------------     ---------------------------------------------
Signature                          Signature

John Bauer, CFO                    T. Saxton VP Finance    H.Rhouri/President
------------------------------     ---------------------------------------------
Name/Title                         Name/Title

September 1, 1999                  Aug 23, 99                        23 Aug 99
------------------------------     ---------------------------------------------
Date                               Date

Confidential                       Page 7
<PAGE>

                              PROFESSIONAL SERVICES
                                AGREEMENT RIDER-1

                                                       Rider Date: July 31, 1999

This is a Rider to the Professional Services Agreement entered into by and
between Breast Cancer International Research Group and DLB SYSTEMS, a business
unit of Premier Research Worldwide, Ltd., dated July 31,1999 (hereinafter the
"Agreement"). DLB hereby grants to the Licensee a non-exclusive,
non-transferable, and non-assignable by either party without the consent of the
other party, which consent shall not be unreasonably withheld, except for an
assignment to an affiliate or to a purchaser of all or substantially all, of the
assets of the business to which this agreement pertains and to use the software
listed below, as provided by DLB and accepted by Licensee at the location listed
below, in accordance with the terms and conditions of the Agreement. In the
event a discrepancy should arise between the provisions of this Rider and those
of the Agreement, the provisions of this Rider shall apply.

1. IMPLEMENTATION SERVICES

   RECORDER Study Implementation                   $150,000

This estimate is based on our prior experience in implementing the RECORDER
application for a CRO initiating a study for a sponsor. The estimate does not
reflect any understanding, on the part of DLB, of the requirements for the study
to be conducted for RPR. In order to develop a more accurate project estimate,
to include goals, objectives, scope, resources, milestones, deliverables and
cost, DLB must conduct a Pre-Implementation Review of the study requirements.
Upon completion of the Pre-Implementation Review, DLB will prepare a detail
project plan for review and approval by BCRIG prior to commencing work.

2. Payment in full on or before January 31, 2000.

The terms of the Agreement not modified by this Rider shall remain in full force
and effect. This Rider, together with the above referenced Agreement,
constitutes the entire agreement of the parties and supersedes all prior
understanding and agreements, whether written or oral.

By signature below, the parties agree to the foregoing:

Accepted By:

DLB SYSTEMS                              BCIRG

Signature: /s/ John Bauer                Signature: /s/ T. Saxton  /s/ H. Rhouri

Name:      John Bauer                    Name:      T. Saxton   H. Rhouri

Title:     CFO                           Title:     VP Finance President

Confidential                       Page 8
<PAGE>
                              PROFESSIONAL SERVICES
                                AGREEMENT RIDER-2

                                                       Rider Date: July 31, 1999

This is a Rider to the Professional Services Agreement entered into by and
between Breast Cancer International Research Group and DLB SYSTEMS, a business
unit of Premier Research Worldwide, Ltd., dated July 31, 1999(hereinafter the
"Agreement"). DLB hereby grants to the Licensee a non-exclusive,
non-transferable, and non-assignable by either party without the consent of the
other party, which consent shall not be unreasonably withheld, except for an
assignment to an affiliate or to a purchaser of all or substantially all, of the
assets of the business to which this agreement pertains and to use the software
listed below, as provided by DLB and accepted by Licensee at the location listed
below, in accordance with the terms and conditions of the Agreement. In the
event a discrepancy should arise between the provisions of this Rider and those
of the Agreement, the provisions of this Rider shall apply.

1. IMPLEMENTATION SERVICES

   MONITOR Study Implementation                    $50,000

This estimate is based on our prior experience in implementing the MONITOR
application for a CRO initiating a study for a sponsor. The estimate does not
reflect any understanding, on the part of DLB, of the requirements for the study
to be conducted for RPR. In order to develop a more accurate project estimate,
to include goals, objectives, scope, resources, milestones, deliverables and
cost, DLB must conduct a Pre-Implementation Review of the study requirements.
Upon completion of the Pre-Implementation Review, DLB will prepare a detail
project plan for review and approval by BCRIG prior to commencing work.

2. Payment in full on or before January 31, 2000.

The terms of the Agreement not modified by this Rider shall remain in full force
and effect. This Rider, together with the above referenced Agreement,
constitutes the entire agreement of the parties and supersedes all prior
understanding and agreements, whether written or oral.

By signature below, the parties agree to the foregoing:

Accepted By:

DLB SYSTEMS                               BCIRG

Signature: /s/ John Bauer                 Signature: /s/ T. Saxton /s/ H. Rhouri

Name:      John Bauer                     Name:      T. Saxton  H. Rhouri

Title:     CFO                            Title:     VP Finance President

Confidential                       Page 9
<PAGE>

                              PROFESSIONAL SERVICES
                                AGREEMENT RIDER-3

                                                       Rider Date: July 31, 1999

This is a Rider to the Professional Services Agreement entered into by and
between Breast Cancer International Research Group and DLB SYSTEMS, a business
unit of Premier Research Worldwide, Ltd., dated July 31, 1999(hereinafter the
"Agreement"). DLB hereby grants to the Licensee a non-exclusive,
non-transferable, and non-assignable by either party without the consent of the
other party, which consent shall not be unreasonably withheld, except for an
assignment to an affiliate or to a purchaser of all or substantially all, of the
assets of the business to which this agreement pertains and to use the software
listed below, as provided by DLB and accepted by Licensee at the location listed
below, in accordance with the terms and conditions of the Agreement. In the
event a discrepancy should arise between the provisions of this Rider and those
of the Agreement, the provisions of this Rider shall apply.

1. IMPLEMENTATION SERVICES

   ALERT Study Implementation                      $50,000

This estimate is based on our prior experience in implementing the ALERT
application for a CRO initiating a study for a sponsor. The estimate does not
reflect any understanding, on the part of DLB, of the requirements for the study
to be conducted for RPR. In order to develop a more accurate project estimate,
to include goals, objectives, scope, resources, milestones, deliverables and
cost, DLB must conduct a Pre-Implementation Review of the study requirements.
Upon completion of the Pre-Implementation Review, DLB will prepare a detail
project plan for review and approval by BCRIG prior to commencing work.

2. Payment in full on or before January 31, 2000.

The terms of the Agreement not modified by this Rider shall remain in full force
and effect. This Rider, together with the above referenced Agreement,
constitutes the entire agreement of the parties and supersedes all prior
understanding and agreements, whether written or oral.

By signature below, the parties agree to the foregoing:

Accepted By:

DLB SYSTEMS                               BCIRG

Signature: /s/ John Bauer                 Signature: /s/ T. Saxton /s/ H. Rhouri

Name:      John Bauer                     Name:      T. Saxton  H. Rhouri

Title:     CFO                            Title:     VP Finance President

Confidential                       Page 10
<PAGE>

                              PROFESSIONAL SERVICES
                                AGREEMENT RIDER-4

                                                       Rider Date: July 31, 1999

This is a Rider to the Professional Services Agreement entered into by and
between Breast Cancer International Research Group and DLB SYSTEMS, a business
unit of Premier Research Worldwide, Ltd., dated July 31, 1999(hereinafter the
"Agreement"). DLB hereby grants to the Licensee a non-exclusive,
non-transferable, and non-assignable by either party without the consent of the
other party, which consent shall not be unreasonably withheld, except for an
assignment to an affiliate or to a purchaser of all or substantially all, of the
assets of the business to which this agreement pertains and to use the software
listed below, as provided by DLB and accepted by Licensee at the location listed
below, in accordance with the terms and conditions of the Agreement. In the
event a discrepancy should arise between the provisions of this Rider and those
of the Agreement, the provisions of this Rider shall apply.

1. IMPLEMENTATION SERVICES

   Implementation and Education for 400 Single     $100,000 for every 100 single
   User Licenses of RECORDER Remote                user license increment or
                                                   fraction thereof

   Services to Include:
      Technical Architecture Definition
         -        Network
         -        Communications
         -        PC
      Technical Architecture Validation
      Software Installation and Distribution Plan
      Backup and Recovery Plan
      End User Education
   Scope of Services assumes standard/identical PC and/or network configurations
at all sites.

2. Payment in full on or before March 31, 2000.

The terms of the Agreement not modified by this Rider shall remain in full force
and effect. This Rider, together with the above referenced Agreement,
constitutes the entire agreement of the parties and supersedes all prior
understanding and agreements, whether written or oral.

By signature below, the parties agree to the foregoing:

Accepted By:

DLB SYSTEMS                               BCIRG

Signature: /s/ John Bauer                 Signature: /s/ T. Saxton /s/ H. Rhouri

Name:      John Bauer                     Name:      T. Saxton  H. Rhouri

Title:     CFO                            Title:     VP Finance President

Confidential                       Page 11                               3/22/00<PAGE>

                           eResearch Technology, Inc.

                               SERIES A PREFERRED

                            STOCK PURCHASE AGREEMENT

                                 March 24, 2000

<PAGE>

                                TABLE OF CONTENTS
<TABLE>
<CAPTION>
                                                                                                                   Page
                                                                                                                   ----
<S>      <C>                                                                                                         <C>
1.       Purchase and Sale of Stock...................................................................................1

         1.1      Authorization of the Shares.........................................................................1
         1.2      Sale and Issuance of Series A Preferred Stock.......................................................1
         1.3      Filing of Certificate of Designation................................................................1
         1.4      Closing Date........................................................................................1

2.       Representations and Warranties of the Company................................................................1

         2.1      Organization, Good Standing and Qualification.......................................................1
         2.2      Capitalization and Voting Rights....................................................................2
         2.3      Subsidiaries; Investments...........................................................................2
         2.4      Authorization.......................................................................................3
         2.5      Governmental Consents...............................................................................3
         2.6      Litigation..........................................................................................3
         2.7      Proprietary Information and Inventions Agreements...................................................3
         2.8      Title to Property and Assets........................................................................4
         2.9      Financial Statements; Liabilities...................................................................4
         2.10     Material Contracts and Other Commitments............................................................4
         2.11     Proprietary Rights..................................................................................4
         2.12     Compliance with Other Instruments...................................................................5
         2.13     Related Party Transactions..........................................................................5
         2.14     Licenses; Permits...................................................................................5
         2.15     Registration Rights.................................................................................6
         2.16     Corporate Documents.................................................................................6
         2.17     Changes.............................................................................................6
         2.18     Tax Returns, Payments and Elections.................................................................7
         2.19     Insurance...........................................................................................7
         2.20     Minute Books........................................................................................7
         2.21     Employee Matters....................................................................................7
         2.22     Millennium Compliance...............................................................................7
         2.23     Disclosure..........................................................................................7

3.       Representations and Warranties of Parent.....................................................................7

         3.1      Organization, Good Standing and Qualification.......................................................8
         3.2      Authorization.......................................................................................8
         3.3      Governmental Consents...............................................................................8

4.       Investment Representations, Warranties and Covenants of Purchaser............................................8

         4.1      Authorization.......................................................................................8
         4.2      Purchase Entirely for Own Account...................................................................8
         4.3      Disclosure of Information...........................................................................9

</TABLE>
                                      -i-
<PAGE>

                                TABLE OF CONTENTS
                                  (continued)
<TABLE>
<CAPTION>
                                                                                                                   Page
                                                                                                                   ----
<S>      <C>                                                                                                         <C>
         4.4      Investment Experience...............................................................................9
         4.5      Accredited Investor.................................................................................9
         4.6      Restricted Securities...............................................................................9
         4.7      Further Limitations on Disposition..................................................................9
         4.8      Legends.............................................................................................9
         4.9      Tax Advisors.......................................................................................10

5.       Conditions of Purchaser's Obligations at Closing............................................................10

         5.1      Representations and Warranties.....................................................................10
         5.2      Performance........................................................................................10
         5.3      Qualifications.....................................................................................10
         5.4      Proceedings and Documents..........................................................................10
         5.5      Transaction Documents..............................................................................11
         5.6      Certificate of Designation.........................................................................11
         5.7      Legal Opinion......................................................................................11
         5.8      No Legal Proceedings...............................................................................11
         5.9      Compliance Certificate.............................................................................11
         5.10     Due Diligence; Schedule of Exceptions..............................................................12
         5.11     Board of Directors.................................................................................12

6.       Conditions of the Company's Obligations at Closing..........................................................12

         6.1      Representations and Warranties.....................................................................12
         6.2      Qualifications.....................................................................................12
         6.3      Transaction Documents..............................................................................12
         6.4      Certificate of Designation.........................................................................12

7.       Covenants of the Company....................................................................................12

         7.1      Prompt Payment of Taxes............................................................................12
         7.2      Maintenance of Insurance...........................................................................13
         7.3      Compliance with Laws...............................................................................13
         7.4      Keeping of Records and Books of Account............................................................13
         7.5      Maintenance of Properties..........................................................................13
         7.6      Obligations........................................................................................13
         7.7      Public Disclosures.................................................................................13
         7.8      Warrant Agreement..................................................................................13

8.       Miscellaneous...............................................................................................14

         8.1      Successors and Assigns.............................................................................14
         8.2      Governing Law......................................................................................14
         8.3      Counterparts.......................................................................................14

</TABLE>

                                      -ii-
<PAGE>

                                TABLE OF CONTENTS
                                  (continued)
<TABLE>
<CAPTION>
                                                                                                                   Page
                                                                                                                   ----
<S>      <C>                                                                                                         <C>

         8.4      Titles and Subtitles...............................................................................14
         8.5      Notices............................................................................................14
         8.6      Finder's Fee.......................................................................................14
         8.7      Expenses...........................................................................................14
         8.8      Amendment and Waivers..............................................................................14
         8.9      Severability.......................................................................................15
         8.10     Aggregation of Stock...............................................................................15
         8.11     GAAP...............................................................................................15
         8.12     Entire Agreement...................................................................................15

</TABLE>
                                     -iii-

<PAGE>

                                    EXHIBITS

A.   Certificate of Designation

B.   Schedule of Exceptions

C.   Investor Rights Agreement

D.   Warrant Agreement

E.   Option Agreement

F.   Legal Opinion of Company Counsel

G.   Legal Opinion of Parent Counsel

                                      -iv-

<PAGE>

                            eResearchTechnology, Inc.

                   SERIES A PREFERRED STOCK PURCHASE AGREEMENT

         THIS SERIES A PREFERRED STOCK PURCHASE AGREEMENT (this "Agreement") is
entered into as of March 24, 2000, by and among eResearchTechnology, Inc., a
Delaware corporation (the "Company"), Premier Research Worldwide, Ltd., a
Delaware corporation ("Parent"), and Communicade Inc., a Delaware corporation
("Purchaser").

         THE PARTIES HEREBY AGREE AS FOLLOWS:

         1. Purchase and Sale of Stock.

            1.1 Authorization of the Shares. The Company has, or before the
Closing (as hereinafter defined) will have, authorized the sale and issuance of
95,000 shares of its Series A Preferred Stock (the "Series A Preferred Stock"),
having the rights, restrictions, privileges and preferences as set forth in the
Company's Series A Preferred Stock in the form attached hereto as Exhibit A (the
"Certificate of Designation").

            1.2 Sale and Issuance of Series A Preferred Stock. Subject to the
terms and conditions of this Agreement, Purchaser agrees to purchase at the
Closing, and the Company agrees to sell and issue to Purchaser at the Closing,
95,000 shares of the Company's Series A Preferred Stock (the "Shares"), at a
purchase price of $100 per share, or an aggregate purchase price of $9,500,000
(the "Purchase Price").

            1.3 Filing of Certificate of Designation. The Company shall adopt
and file with the Secretary of State of Delaware on or before the Closing (as
defined below) the Certificate of Designation.

            1.4 Closing Date. The closing of the purchase and sale of the Shares
hereunder shall be held at the offices of Jones, Day, Reavis & Pogue, 599
Lexington Avenue, New York, New York at 10:00 a.m., local time, on March 24,
2000 (the "Closing") or at such other time and place as shall be mutually agreed
upon by the Company and Purchaser. At the Closing, Purchaser shall tender to the
Company, by check or wire transfer, the Purchase Price for the Shares. At the
Closing, the Company shall issue to Purchaser a certificate or certificates
representing the Shares purchased by Purchaser.

         2. Representations and Warranties of the Company. Except as set forth
on the Schedule of Exceptions attached as Exhibit B hereto (the "Schedule of
Exceptions"), the Company hereby represents and warrants to Purchaser as
follows, as of the date hereof and as of the Closing:

            2.1 Organization, Good Standing and Qualification. The Company is a
corporation duly organized, validly existing and in good standing under the laws
of the State of Delaware and is qualified to do business in every jurisdiction
in which its ownership of property or conduct of business requires it to be so
qualified, except where the failure to obtain such qualification could not
reasonably be expected to have a material adverse effect on the business,
operating results, assets or financial condition of the Company and its
subsidiaries taken as a whole (a "Material Adverse Effect"). The Company
possesses all requisite corporate power and authority and all material licenses,
permits and authorizations necessary to own and operate its properties, to carry
on its business as now conducted and as proposed to be conducted and to carry
out the

<PAGE>

transactions contemplated by this Agreement. The copies of the Company's
charter documents and bylaws which have been furnished to Purchaser reflect all
amendments made thereto at any time prior to the date of this Agreement and are
complete and correct.

            2.2 Capitalization and Voting Rights.

                (a) The authorized capital of the Company consists, or will
consist of:

                    (i) Preferred Stock. 10,000,000 shares, without par value
(the "Preferred Stock"), of which 95,000 shares have been designated Series A
Preferred Stock, none of which are issued and outstanding prior to the Closing
and all of which will be sold pursuant to this Agreement at the Closing. The
rights, privileges and preferences of the Series A Preferred Stock are as set
forth in the Certificate of Designation.

                    (ii) Common Stock. 50,000,000 shares of Common Stock, par
value $.01 per share (the "Common Stock"), of which 1,000 shares are issued and
outstanding as of the date hereof.

                    (iii) Warrant. In accordance with Section 7.8, upon the
consummation of an Initial Public Offering (as defined in Section 7.8), the
Company will issue a warrant to Purchaser to purchase 2.5% of the then
outstanding shares of its Common Stock pursuant to the terms of the Warrant
Agreement (as defined in Section 2.4).

                (b) Except for (i) the conversion privileges of the Series A
Preferred Stock to be issued under this Agreement and (ii) the warrant described
in Section 2.2(a) above, there are not outstanding any stock, options, warrants
or other securities convertible or exchangeable for any shares of the Company's
capital stock or containing any profits participation features, or any
outstanding rights or options to subscribe for or purchase the Company's capital
stock or any stock or securities convertible into or exchangeable for the
Company's capital stock or any stock appreciation rights or phantom stock plans,
or obligations for the purchase or acquisition from the Company of any shares of
its capital stock. The Company is not a party or subject to any agreement or
understanding and there is no agreement or understanding between any other
persons or entities which affects or relates to the voting or giving of written
consents with respect to any security or by a director of the Company.

                (c) As of the Closing, the Company shall not be subject to any
obligation (contingent or otherwise) to repurchase or otherwise acquire or
retire any shares of its capital stock or any warrants, options or other rights
to acquire its capital stock.

            2.3 Subsidiaries; Investments. The Company does not presently own or
control, directly or indirectly, any interest in any other corporation,
association, or other business entity. The Company is not a participant in any
joint venture, partnership or similar arrangement. Each such subsidiary is duly
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation, possesses all requisite corporate power and
authority and all material licenses, permits and authorizations necessary to own
its properties and to carry on its business as now being conducted and as
presently proposed to be conducted and is qualified to do business in every
jurisdiction in which its ownership of property or the conduct of business
requires to be so qualified, except where the failure to obtain such
qualification would not have a Material Adverse Effect. All of the outstanding
shares of capital stock of each such subsidiary are validly issued, fully paid
and nonassessable, and all such shares are owned by the Company, free and clear
of any lien, and are not subject to any option or right to purchase any such
shares. Neither the Company nor any

                                      -2-
<PAGE>

such subsidiary owns or holds the right to acquire any shares of stock or any
other security or interest in any other person or entity.

            2.4 Authorization. All corporate action on the part of the Company,
its officers, directors and stockholders necessary for the authorization,
execution and delivery of this Agreement, the Investor Rights Agreement among
the Company, Parent and Purchaser, substantially in the form attached hereto as
Exhibit C (the "Investor Rights Agreement"), the Warrant Agreement among the
Company and Purchaser, substantially in the form attached hereto as Exhibit D
(the "Warrant Agreement"), the Put Option Agreement among the Company, Parent
and Purchaser, substantially in the form attached hereto as Exhibit E (the
"Option Agreement", and together with this Agreement, the Investor Rights
Agreement and the Warrant Agreement, the "Transaction Documents"), the
performance of all obligations of the Company under the Transaction Documents,
and the authorization, issuance (or reservation for issuance), sale and delivery
of the Series A Preferred Stock being sold hereunder constitute valid and
legally binding obligations of the Company, enforceable in accordance with their
respective terms, except (i) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium, and other laws of general application affecting
enforcement of creditors' rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief, or other equitable
remedies, and (iii) to the extent the indemnification provisions contained in
the Investor Rights Agreement may be limited by applicable federal or state
securities laws. The Series A Preferred Stock being purchased by Purchaser
hereunder, when issued, sold and delivered in accordance with the terms of this
Agreement for the consideration expressed herein, will be duly and validly
issued, fully paid and nonassessable.

            2.5 Governmental Consents. No consent, approval, order or
authorization of, or registration, qualification, designation, declaration or
filing with, any federal, state or local governmental authority on the part of
the Company is required in connection with the consummation of the transactions
contemplated by this Agreement, except for the filing of the Certificate of
Designation with the Delaware Secretary of State.

            2.6 Litigation. There is no action, suit, proceeding or
investigation pending or currently threatened against the Company that questions
the validity of any of the Transaction Documents, or the right of the Company to
enter into any such agreement or to consummate the transactions contemplated
thereunder, or that might result, either individually or in the aggregate, in a
Material Adverse Effect, financially or otherwise, or any change in the current
equity ownership of the Company. The Company is not subject to any arbitration
proceedings under collective bargaining agreements or otherwise or, to the
Company's knowledge, any governmental investigation or inquiry and, to the
Company's knowledge, there is no reasonable basis for any of the foregoing. The
foregoing includes, without limitation, actions, suits, proceedings or
investigations pending or threatened involving (a) the prior employment of any
of the Company's employees, or their use in connection with the Company's
business of any information allegedly proprietary to any of their former
employers, or (b) negotiations by the Company with potential investors in the
Company. The Company is not a party or subject to the provisions of any order,
writ, injunction, judgment or decree of any court or government agency or
instrumentality. There is no action, suit, proceeding or investigation by the
Company currently pending or that the Company intends to initiate.

            2.7 Proprietary Information and Inventions Agreements. Each
employee, officer and consultant of the Company has executed a Proprietary
Information and Inventions Assignment Agreement. The Company is not aware that
any of its employees, officers or

                                      -3-
<PAGE>

consultants are in violation thereof, and the Company will use its best efforts
to prevent any such violation. The Company is not aware that any officer or key
employee intends to terminate employment with the Company, nor does the Company
have a present intention to terminate the employment of any of the foregoing.
Subject to general principles relating to wrongful termination of employees, the
employment of each officer and employee of the Company is terminable at the will
of the Company.

            2.8 Title to Property and Assets. The Company owns its property and
assets free and clear of all mortgages, liens, loans and encumbrances, except
such encumbrances and liens that arise in the ordinary course of business and do
not materially impair the Company's ownership or use of such property or assets.
With respect to the property and assets it leases, the Company is in compliance
with such leases and holds a valid leasehold interest free of any liens, claims
or encumbrances.

            2.9 Financial Statements; Liabilities. The Company commenced
operations on January 1, 2000. The Company's audited financial statements
(balance sheet, statement of operations, and statements of stockholders' equity
and cash flows) at and for the period ended December 31, 1999, (the "Financial
Statements") present the historical operating revenues, expenses, assets and
liabilities of Parent, are complete and correct in all material respects, are
consistent with the books and records of the Company, and have been prepared in
accordance with United States generally accepted accounting principles applied
on a consistent basis ("GAAP") throughout the periods indicated. The Financial
Statements fairly present the financial condition and operating results of the
Company as of the dates, and for the periods, indicated therein.

         Except as set forth in the Financial Statements, the Company has no
material obligations or liabilities, other than (i) liabilities incurred in the
ordinary course of business subsequent to the December 31, 1999 balance sheet
(the "December Balance Sheet"), none of which is a liability resulting from a
breach of contract or breach of warranty or claim of infringement of an
Intellectual Property Right (as defined below) of a third party, and (ii)
obligations under contracts and commitments incurred in the ordinary course of
business, and not required under GAAP to be reflected in the Financial
Statements, which, individually or in the aggregate, are not material to the
financial condition of the Company, exclusive of obligations for salaries
accrued since December 31, 1999 but not yet due, and recurring trade payables
not greater than $100,000 in the aggregate incurred in the ordinary course of
business.

            2.10 Material Contracts and Other Commitments. Except for the
Transaction Documents there are no agreements, instruments or contracts to which
the Company is a party or by which it is bound, other than the following
(collectively, the "Contracts"): (i) contracts for the purchase of supplies and
services that were entered into in the ordinary course of business, do not
involve the payment of more than $50,000 in cash, goods, or services, and do not
extend for more than one date hereof, (ii) contracts entered into in the
ordinary course of business that do not involve amounts in excess of 5% of the
Company's 1999 revenues, and (iii) contracts terminable at will by the Company
on no more than 30 days notice without cost or liability to the Company and are
not material to the conduct of the Company's business. All of the Contracts are
valid, binding and in full force and effect in all material respects and
enforceable by the Company in accordance with their respective terms in all
material respects, subject to the effect of applicable bankruptcy, insolvency,
reorganization, fraudulent conveyance, moratorium, usury or other laws of
general application relating to or affecting enforcement of creditors' rights
and rules or laws concerning equitable remedies. The Company is not in material
default under any of such Contracts. To the knowledge of the Company, no other
party to any of the Contracts is in material default thereunder.

            2.11 Proprietary Rights.

                                      -4-
<PAGE>

                (a) At the time of the Closing the Company owns, or has valid
license rights with respect to, all patents, patent applications, if any,
trademarks, service marks, trade names, inventions, processes, formulae, trade
secrets, franchises, copyrights and other proprietary rights (collectively,
"Intellectual Property Rights") employed in or necessary for the operation of
its business as now conducted with no known infringement of or conflict with the
rights of others. Such ownership and title are exclusive and not subject to
termination without the Company's consent. To the Company's knowledge, the
conduct of its business does not infringe or conflict with any intellectual
property rights of any third party. There are no outstanding options, licenses,
or agreements of any kind relating to the foregoing Intellectual Property
Rights, nor is the Company bound by or a party to any options, licenses or
agreements of any kind with respect to the Intellectual Property Rights of any
other person or entity. The Company is not aware of any third party that has
misappropriated or is infringing or violating any of its Intellectual Property
Rights. The Company has not received any communications alleging that the
Company has violated or, by conducting its business as proposed, would violate
any of the Intellectual Property Rights of any other person or entity, and there
have been no claims made against the Company asserting the invalidity or
unenforceability or any of the Company's Intellectual Property Rights. The
Company does not believe it is or will be necessary to use any inventions of any
of its employees (or persons it currently intends to hire) made prior to their
employment by the Company.

                (b) The transactions contemplated by this Agreement shall have
no Material Adverse Effect on the Company's right, title and interest in and to
the Company's Intellectual Property Rights.

            2.12 Compliance with Other Instruments. The Company is not in
violation of, or default on (i) any term of its Restated Certificate or Bylaws,
or (ii) any statute, rule or regulation applicable to the Company, or any term
of any material contract, mortgage, indenture, judgment, writ, decree, order or
instrument to which the Company is subject and a violation of which would have a
Material Adverse Effect. The execution, delivery and performance of this
Agreement and the Investors Rights Agreement, and the consummation of the
transactions contemplated hereby and thereby will not result in any such
violation or be in conflict with or constitute either a default under any such
instrument, judgment, order, writ, decree or contract or an event that gives any
third party the right to modify, terminate or accelerate any obligation under
any such instrument, judgment, order, writ, decree or contract or that results
in the creation of any lien, charge or encumbrance upon any assets of the
Company or the suspension, revocation, impairment, forfeiture, or nonrenewal of
any material permit, license, authorization, or approval applicable to the
Company, the effect which would in any such case constitute a Material Adverse
Effect.

            2.13 Related Party Transactions. No employee, officer, stockholder
or director of the Company or member of his or her immediate family is indebted
to the Company, nor is the Company indebted (or committed to make loans or
extend or guarantee credit) to any of them, other than (i) for payment of salary
for services rendered, (ii) reimbursement for reasonable expenses incurred on
behalf of the Company, and (iii) for other standard employee benefits made
generally available to all employees including stock option agreements
outstanding under any stock option plan approved by the Board of Directors of
the Company, nor does any such person have any interest in any material asset or
right of the Company. To the Company's knowledge, no officer, director, or
stockholder or any member of their immediate families is, directly or
indirectly, interested in any contract with the Company (other than such
contracts as relate to any such person's ownership of capital stock or other
securities of the Company).

            2.14 Licenses; Permits. The Company has all franchises, permits,
licenses, and any similar authority necessary for the conduct of its business as
now being conducted by it, the lack of which

                                      -5-
<PAGE>

could have a Material Adverse Effect, and believes it can obtain, without undue
burden or expense, any similar authority for the conduct of its business as
presently planned to be conducted. The Company is not in default in any material
respect under any of such franchises, permits, licenses or other similar
authority.

            2.15 Registration Rights. Except as provided in the Investor Rights
Agreement, the Company has not granted or agreed to grant any registration
rights, including piggyback rights, to any person or entity.

            2.16 Corporate Documents. Except for amendments necessary to satisfy
representations and warranties or conditions contained herein (the form of which
amendments has been approved by Purchaser), the Certificate of Designation and
bylaws of the Company are in the form provided to Purchaser.

            2.17 Changes. Since December 31, 1999, there has not been:

                    (i) any material adverse change in the assets, liabilities,
financial condition, operations, business prospects, employee relations,
customer or supplier relations or operating results of the Company from that
reflected in the Financial Statements;

                    (ii) any action by the Company that would have required the
consent of the holders of a majority of the Series A Preferred Stock pursuant to
the Certificate of Designation or the Investor Rights Agreement;

                    (iii) any investment in or steps taken by the Company to
incorporate any subsidiary;

                    (iv) any damage, destruction or loss, whether or not covered
by insurance, that would constitute a Material Adverse Effect;

                    (v) any waiver by the Company of a valuable right or of a
material debt owed to it;

                    (vi) any satisfaction or discharge of any lien, claim or
encumbrance or payment of any obligation by the Company, except in the ordinary
course of business and that is not material to the assets, properties, financial
condition, operating results or business of the Company (as such business is
presently conducted and as it is proposed to be conducted);

                    (vii) any change or amendment to a material contract or
arrangement by which the Company or any of its assets or properties is bound or
subject;

                    (viii) any loans or guarantees made by the Company to or for
the benefit of its employees, officers or directors, or any members of their
immediate families, other than travel advances and other advances made in the
ordinary course of its business;

                    (ix) any change in any compensation arrangement or agreement
with any key employee;

                                      -6-
<PAGE>

                    (x) any sale, assignment or transfer of any patents,
trademarks, copyrights, trade secrets, other intangible assets or other
Intellectual Property Rights; or

                    (xi) any resignation or termination of employment of any key
officer of the Company.

                (b) The Company has not at any time made payments for political
contributions or made any bribes, kickback payments or other illegal payments.

            2.18 Tax Returns, Payments and Elections. The Company has filed all
tax returns and reports (including information returns and reports) as required
by law. The Company has paid all taxes and other assessments due, except those
contested by it in good faith that are listed on Exhibit B. The provision for
taxes of the Company as shown in the Financial Statements is adequate for taxes
due or accrued as of the date thereof. The Company has not elected pursuant to
the Internal Revenue Code of 1986, as amended (the "Code"), to be treated as a
Subchapter S corporation or a collapsible corporation pursuant to Section
1362(a) or Section 341(f) of the Code, nor has it made any other elections
pursuant to the Code (other than elections that relate solely to methods of
accounting, depreciation or amortization) that would have a Material Adverse
Effect.

            2.19 Insurance. The Company has in full force and effect fire and
casualty insurance policies, with extended coverage, in customary amounts
(subject to reasonable deductibles) and that the Company believes is sufficient
for its business as conducted and as proposed to be conducted.

            2.20 Minute Books. The minute books of the Company made available to
Purchaser contain minutes of all meetings of directors and stockholders since
the time of incorporation and reflect all transactions referred to in such
minutes accurately in all material respects.

            2.21 Employee Matters. The Company is not aware that any officer or
key employee, or that any group of key employees, currently intends to terminate
their employment with the Company. The employment of each officer and employee
of the Company is terminable at the will of the Company.

            2.22 Millennium Compliance. The failure by the Company's computer
systems to be capable of the following during and/or after January 1, 2000, will
not have a Material Adverse Effect on the Company: (a) handling date information
involving all and any dates, including accepting input, providing output and
performing date calculations in whole or in part; (b) operating accurately
without interruption on and in respect of any and all dates and without change
in performance; (c) responding to and processing two digit year input without
creating any ambiguity as to the century; and (d) storing and providing date
input information without creating any ambiguity as to the century.

            2.23 Disclosure. Neither this Agreement nor any of the Exhibits,
Schedules, or closing certificates hereto contain any untrue statement of a
material fact or omit a material fact necessary to make each statement contained
herein or therein, in light of the circumstances under which it is made, not
misleading.

         3. Representations and Warranties of Parent. Parent hereby represents
and warrants to Purchaser as follows, as of the date hereof and as of the
Closing:

                                      -7-
<PAGE>

            3.1 Organization, Good Standing and Qualification. Parent is a
corporation duly organized, validly existing and in good standing under the laws
of the State of Delaware and is qualified to do business in every jurisdiction
in which its ownership of property or conduct of business requires it to be so
qualified, except where the failure to obtain such qualification could not
reasonably be expected to have a material adverse effect on the business,
operating results, assets or financial condition of Parent and its subsidiaries
taken as a whole. Parent possesses all requisite corporate power and authority
and all material licenses, permits and authorizations necessary to own and
operate its properties, to carry on its business as now conducted and as
proposed to be conducted and to carry out the transactions contemplated by this
Agreement. The copies of Parent's charter documents and bylaws which have been
furnished to Purchaser reflect all amendments made thereto at any time prior to
the date of this Agreement and are complete and correct.

            3.2 Authorization. All corporate action on the part of Parent, its
officers, directors and stockholders necessary for the authorization, execution
and delivery of this Agreement and the Option Agreement, the performance of all
obligations of Parent under this Agreement and the Option Agreement, and the
authorization, issuance (or reservation for issuance), sale and delivery of the
shares of common stock of Parent issuable pursuant to the Option Agreement (the
"Parent Common Stock") constitute valid and legally binding obligations of
Parent, enforceable in accordance with their respective terms, except (i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium, and
other laws of general application affecting enforcement of creditors' rights
generally and (ii) as limited by laws relating to the availability of specific
performance, injunctive relief, or other equitable remedies. The Parent Common
Stock, when issued, sold and delivered in accordance with the terms of the
Option Agreement, will be duly and validly issued, fully paid and nonassessable.

            3.3 Governmental Consents. No consent, approval, order or
authorization of, or registration, qualification, designation, declaration or
filing with, any federal, state or local governmental authority on the part of
the Company is required in connection with the consummation of the transactions
contemplated by this Agreement, except for the filing of the Certificate of
Designation with the Delaware Secretary of State.

         4. Investment Representations, Warranties and Covenants of Purchaser.
Purchaser hereby represents and warrants that:

            4.1 Authorization. Purchaser has full power and authority to enter
into this Agreement and the other Transaction Documents, and each such
agreement, when executed and delivered, will constitute a valid and legally
binding obligation of Purchaser, enforceable against Purchaser in accordance
with its terms except (i) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium, and other laws of general application affecting
enforcement of creditors' rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief, or other equitable
remedies, and (iii) to the extent that the indemnification provisions contained
in the Investor Rights Agreement may be limited by applicable laws.

            4.2 Purchase Entirely for Own Account. This Agreement is made with
Purchaser in reliance upon Purchaser's representation to the Company, which by
Purchaser's execution of this Agreement Purchaser hereby confirms, that the
Series A Preferred Stock to be received by Purchaser and the Common Stock
issuable upon conversion thereof (collectively, the "Securities") will be
acquired for investment for Purchaser's own account, not as a nominee or agent,
and not with a view to the resale or distribution of any part thereof, and that
Purchaser has no present intention of selling, granting any participation in, or
otherwise distributing the same. By executing this Agreement, Purchaser further
represents that Purchaser does not

                                      -8-
<PAGE>

have any contract, undertaking, agreement or arrangement with any person to
sell, transfer or grant participation to such person or to any third person,
with respect to any of the Securities.

            4.3 Disclosure of Information. Purchaser believes it has received
all the information it considers necessary or appropriate for deciding whether
to purchase the Series A Preferred Stock. Purchaser further represents that it
has had an opportunity to ask questions and receive answers from the Company
regarding the terms and conditions of the offering of the Series A Preferred
Stock and the business, properties, prospects and financial condition of the
Company. The foregoing, however, does not limit or modify the representations
and warranties of the Company in Section 2 of this Agreement or the right of
Purchaser to rely thereon.

            4.4 Investment Experience. Purchaser is an investor in securities of
companies in the development stage and acknowledges that it is able to fend for
itself, can bear the economic risk of its investment, and has such knowledge and
experience in financial or business matters that it is capable of evaluating the
merits and risks of the investment in the Series A Preferred Stock. Purchaser
also represents it has not been organized solely for the purpose of acquiring
the Series A Preferred Stock.

            4.5 Accredited Investor. Purchaser is an "accredited investor"
within the meaning of Securities and Exchange Commission ("SEC") Rule 501 of
Regulation D, as presently in effect.

            4.6 Restricted Securities. Purchaser understands that the Securities
it is purchasing are characterized as "restricted securities" under the federal
securities laws inasmuch as they are being acquired from the Company in a
transaction not involving a public offering and that under such laws and
applicable regulations such securities may be resold without registration under
the Securities Act of 1933, as amended (the "Act"), only in certain limited
circumstances. In addition, Purchaser represents that it is familiar with SEC
Rule 144, as presently in effect, and understands the resale limitations imposed
thereby and by the Act. Purchaser understands that no public market presently
exists for the Series A Preferred Stock or Common Stock of the Company, and that
there are no assurances that any such market will be created.

            4.7 Further Limitations on Disposition. Without in any way limiting
the above, Purchaser further agrees not to make any disposition of all or any
portion of the Securities unless and until the transferee has agreed in writing
for the benefit of the Company to be bound by this Section 4 and Section 8 of
this Agreement and Sections 1.9, 1.12 and 2 of the Investor Rights Agreement,
and:

                (a) There is then in effect a registration statement under the
Act covering such proposed disposition and such disposition is made in
accordance with such registration statement; or

                (b) (i) Purchaser shall have notified the Company of the
proposed disposition and shall have furnished the Company with a detailed
statement of the circumstances surrounding the proposed disposition, and (ii) if
reasonably requested by the Company, Purchaser shall have furnished the Company
with an opinion of counsel, reasonably satisfactory to the Company, that such
disposition will not require registration of such shares under the Act.

            4.8 Legends. It is understood that the certificate(s) evidencing the
Shares shall bear the following legends:

                                      -9-
<PAGE>

                   THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED
            FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
            OF 1933, AS AMENDED. SUCH SHARES MAY NOT BE SOLD OR TRANSFERRED IN
            THE ABSENCE OF SUCH REGISTRATION OR UNLESS THE COMPANY RECEIVES AN
            OPINION OF COUNSEL REASONABLY ACCEPTABLE TO IT STATING THAT SUCH
            SALE OR TRANSFER IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS
            DELIVERY REQUIREMENTS OF SAID ACT. COPIES OF THE AGREEMENTS COVERING
            THE PURCHASE OF THESE SHARES AND RESTRICTING THEIR TRANSFER MAY BE
            OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD
            OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY AT THE PRINCIPAL
            EXECUTIVE OFFICES OF THE COMPANY.

                   THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO
            CERTAIN RIGHTS OF FIRST REFUSAL AND MARKET STAND-OFF PROVISIONS
            CONTAINED IN THE COMPANY'S INVESTOR RIGHTS AGREEMENT DATED MARCH 24,
            2000. A COPY OF SUCH AGREEMENT MAY BE OBTAINED WITHOUT CHARGE UPON
            WRITTEN REQUEST TO THE COMPANY AT ITS PRINCIPAL PLACE OF BUSINESS.

            4.9 Tax Advisors. Purchaser has reviewed with its own tax advisors
the federal, state and local tax consequences of its purchase of Shares, where
applicable, and the transactions contemplated by this Agreement. Purchaser is
relying solely on its own tax advisors and understands that Purchaser (and not
the Company) shall be responsible for Purchaser's own tax liability that may
arise as a result of its purchase of Shares or the transactions contemplated by
this Agreement.

         5. Conditions of Purchaser's Obligations at Closing. The obligations of
Purchaser to purchase Shares at the Closing are subject to the fulfillment of
each of the following conditions:

            5.1 Representations and Warranties. The representations and
warranties of each of the Company and Parent contained in Section 2 and Section
3, respectively, shall be true in all respects (or, if any such representation
is not expressly qualified by "materiality," "Material Adverse Effect" or words
of similar import, then in all material respects) on and as of the date hereof
and as of the Closing with the same effect as though such representations and
warranties had been made on and as of the Closing.

            5.2 Performance. Each of the Company and Parent shall have performed
and complied with all agreements, obligations and conditions contained in this
Agreement that are required to be performed or complied with by it on or before
the Closing.

            5.3 Qualifications. All authorizations, approvals, or permits, if
any, of any governmental authority or regulatory body of the United States or of
any state that are required in connection with the lawful issuance and sale of
the Shares will have been obtained by each of the Company and Parent as of the
Closing.

            5.4 Proceedings and Documents.

                                      -10-
<PAGE>

                (a) All corporate and other proceedings in connection with the
transactions contemplated at the Closing and all documents incident thereto
shall be reasonably satisfactory in form and substance to Purchaser, and
Purchaser shall have received all such counterparts and certified or other
copies of such documents as Purchaser may reasonably request.

                (b) The Company shall have delivered to Purchaser certified
copies of the resolutions duly adopted by the Company's Board of Directors
authorizing the execution, delivery and performance of this Agreement, the other
Transaction Documents, the filing of the Certificate of Designation, the
issuance and sale of the Series A Preferred Stock, the reservation for issuance
of Common Stock upon conversion of the Series A Preferred Stock, and the
consummation of all other transactions contemplated by this Agreement.

                (c) Parent shall have delivered to Purchaser certified copies of
the resolutions duly adopted by Parent's Board of Directors authorizing the
execution, delivery and performance of this Agreement and the Option Agreement
and the reservation of Parent Common Stock for issuance upon exercise of
Purchaser's rights under the Option Agreement.

                (d) The Company shall have delivered to Purchaser certified
copies of the Certificate of Designation and the Company's bylaws, each as in
effect at the Closing. (e) As of the Closing, the Company shall have delivered
to Purchaser a good standing certificate for the Company from the Secretary of
State of Delaware, dated as of a date within 30 days prior to the Closing.

            5.5 Transaction Documents. The Company, Parent, Purchaser and all
other parties thereto shall have entered into the Transaction Documents (other
than the Warrant Agreement).

            5.6 Certificate of Designation. The Certificate of Designation shall
have been filed with the Delaware Secretary of State.

            5.7 Legal Opinion. Duane, Morris & Heckscher LLP, counsel to the
Company, shall have rendered to Purchaser a legal opinion in substantially the
form attached hereto as Exhibit F, and Archer & Greiner, counsel to Parent,
shall have rendered to Purchaser a legal opinion in substantially the form
attached hereto as Exhibit G.

            5.8 No Legal Proceedings. No proceeding challenging this Agreement
or the transactions contemplated hereby or seeking to prohibit, alter, prevent
or materially delay the Closing or seeking damages in connection therewith shall
have been instituted or threatened by any person or entity.

            5.9 Compliance Certificate. (a) The Chairman of the Company shall
deliver to Purchaser at the Closing a certificate stating that the conditions
specified in Sections 5.1 through 5.8 with respect to the Company have been
fulfilled.

                (b) The President of Parent shall deliver to Purchaser at
the Closing a certificate stating that the conditions specified in Sections 5.1
through 5.8 with respect to Parent have been fulfilled.

                                      -11-
<PAGE>

            5.10 Due Diligence; Schedule of Exceptions. Purchaser shall have
completed its financial and legal due diligence review of the Company with the
results thereof satisfactory to Purchaser in its sole discretion, and the
Schedule of Exceptions shall be satisfactory in form and substance to Purchaser
in its sole discretion.

            5.11 Board of Directors. The Company shall have a board of directors
consisting of six directors. As of the Closing, the Board of Directors shall
consist of Sheldon M. Bonovitz, Joseph A. Esposito, Joel Morganroth, Howard D.
Ross, John M. Ryan and one person designated by Purchaser who shall initially be
Thomas L. Harrison.

         6. Conditions of the Company's Obligations at Closing. The obligations
of the Company to sell and issue the Shares at the Closing are subject to the
fulfillment of each of the following conditions:

            6.1 Representations and Warranties. The representations and
warranties of Purchaser contained in Section 4 shall be true in all respects
(or, if any such representation is not expressly qualified by "materiality,"
"Material Adverse Effect" or words similar import, then in all material
respects) on and as of the Closing with the same effect as though such
representations and warranties had been made on and as of the Closing.

            6.2 Qualifications. All authorizations, approvals, or permits, if
any, of any governmental authority or regulatory body of the United States or of
any state that are required in connection with the lawful issuance and sale of
the Securities pursuant to this Agreement shall be duly obtained and effective
as of the Closing.

            6.3 Transaction Documents. The Company, Purchaser and all other
parties thereto shall have entered into the Transaction Documents (other than
the Warrant Agreement).

            6.4 Certificate of Designation. The Certificate of Designation shall
have been filed with the Delaware Secretary of State.

         7. Covenants of the Company. Without limiting any other covenants and
provisions hereof, each of the Company and Parent (where applicable) covenants
and agrees that until the consummation of an underwritten public offering
pursuant to an effective registration under the Act covering the offer and sale
by the Company of its Common Stock in which the aggregate net proceeds to the
Company equal or exceed $25,000,000 (a "Qualified Public Offering"), it will
perform and observe the following covenants and provisions, and will cause each
subsidiary and any other corporation of which it directly or indirectly owns at
least fifty percent (50%) of such corporation's outstanding shares (a
"Subsidiary"), if and when such Subsidiary exists, to perform and observe such
of the following covenants and provisions as are applicable to such Subsidiary.

            7.1 Prompt Payment of Taxes. The Company will promptly pay and
discharge, or cause to be paid and discharged, when due and payable, all lawful
taxes, assessments and governmental charges or levies imposed upon the income,
profits, property or business of the Company or any Subsidiary; provided,
however, that any such tax, assessment, charge or levy need not be paid if the
validity thereof shall currently be contested in good faith by appropriate
proceedings and if the Company shall have set aside on its books

                                      -12-
<PAGE>

adequate reserves with respect thereto, and provided, further, that the Company
will pay all such taxes, assessments, charges or levies forthwith upon the
commencement of proceedings to foreclose any lien which may have attached as
security therefor.

            7.2 Maintenance of Insurance. The Company will maintain insurance
with responsible and reputable insurance companies or associations in such
amounts and covering such risks as is customarily carried by companies engaged
in similar businesses and owning similar properties as the Company.

            7.3 Compliance with Laws. The Company will comply, and cause each
Subsidiary to comply, with the requirements of all applicable foreign and
domestic laws, rules, regulations and orders of any governmental authority,
where noncompliance would have a Material Adverse Effect upon the business or
operations of the Company.

            7.4 Keeping of Records and Books of Account. The Company will keep
adequate records and books of account in which complete entries will be made in
accordance with GAAP, reflecting all financial transactions of the Company.

            7.5 Maintenance of Properties. The Company will maintain and
preserve all of its properties and assets, necessary for the proper conduct of
its business, in good repair, working order and condition, ordinary wear and
tear excepted.

            7.6 Obligations. The Company will comply with all other material
obligations which it incurs pursuant to any contract or agreement, as such
obligations become due, unless and to the extent that (i) the same are being
contested in good faith and by appropriate proceedings and, if necessary,
adequate reserves (as determined in accordance with GAAP) have been established
on its books with respect thereto or (ii) the breach thereof would not have a
Material Adverse Effect.

            7.7 Public Disclosures. The Company shall not disclose Purchaser's
name or identity as an investor in the Company in any press release or other
public announcement or in any document or material filed with any governmental
entity, without the prior written consent of Purchaser (which consent shall not
be unreasonably withheld), unless such disclosure is required by applicable law
or governmental regulations or by order of a court of competent jurisdiction, in
which case prior to making such disclosure, the Company shall give written
notice to Purchaser describing in reasonable detail the proposed content of such
disclosure and shall permit Purchaser to review and comment upon the form and
substance of such disclosure.

            7.8 Warrant Agreement. If the Company consummates an underwritten
public offering pursuant to an effective registration statement under the
Securities Act of 1933, as amended, covering the offer and sale of securities to
the general public for the account of the Company (an "Initial Public
Offering"), then simultaneously therewith the Company shall execute and deliver
to Purchaser the Warrant Agreement, and the Warrant Agreement will specify that
Purchaser is entitled to purchase a number of shares of the Company's Common
Stock equal to 2.5% of the then-outstanding common stock of Company (after
giving effect to the issuance of the shares of Common Stock sold by the Company
in the Initial Public Offering and the conversion of the Series A Preferred
Stock, if applicable) at an exercise price per share equal to 200% of the per
share offering price in the Initial Public Offering less the underwriters'
commission per share.

                                      -13-
<PAGE>

         8. Miscellaneous.

            8.1 Successors and Assigns. Except as otherwise provided herein, the
terms and conditions of this Agreement shall inure to the benefit of and be
binding upon the respective successors and assigns of the parties (including
transferees of any securities of the Company). Nothing in this Agreement,
express or implied, is intended to confer upon any party other than the parties
hereto or their respective successors and assigns any rights, remedies,
obligations, or liabilities under or by reason of this Agreement, except as
expressly provided in this Agreement.

            8.2 Governing Law. This Agreement shall be governed by and construed
under the laws of the State of Delaware, without reference to conflicts of law
rules.

            8.3 Counterparts. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

            8.4 Titles and Subtitles. The titles and subtitles used in this
Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

            8.5 Notices. All notices and other communications required or
permitted hereunder shall be in writing, shall be effective when given, and
shall in any event be deemed to be given upon receipt or, if earlier, (a) five
days after deposit with the U.S. Postal Service or other applicable postal
service, if delivered by first class mail, postage prepaid, (b) upon delivery,
if delivered by hand, (c) one business day after the business day of deposit
with Federal Express or similar overnight courier, freight prepaid or (d) one
business day after the business day of facsimile transmission, if delivered by
facsimile transmission with copy by first class mail, postage prepaid, and shall
be addressed (i) if to Purchaser, at its address set forth on the signature page
to this Agreement, and (ii) if to the Company, at the address of its principal
corporate offices (attention: Chairman), or at such other address as a party may
designate by 10 days' advance written notice to the other party pursuant to the
provisions above.

            8.6 Finder's Fee. Each party represents that it neither is nor will
be obligated for any finders' fee or commission in connection with this
transaction. Purchaser agrees to indemnify and hold harmless the Company from
any liability for any commission or compensation in the nature of a finders' fee
(and the costs and expenses of defending against such liability or asserted
liability) for which Purchaser or any of its officers, partners, employees, or
representative is responsible. The Company agrees to indemnify and hold harmless
Purchaser from any liability for any commission or compensation in the nature of
a finders' fee (and the costs and expenses of defending against such liability
or asserted liability) for which the Company or any of its officers, employees
or representatives is responsible.

            8.7 Expenses. Purchaser shall pay all costs and expenses that it
incurs with respect to the negotiation, execution, delivery and performance of
this Agreement, provided, however, that the Company will reimburse Purchaser for
the reasonable fees and expenses of its counsel in connection with the
transactions contemplated by this Agreement up to a maximum amount of $15,000.

            8.8 Amendment and Waivers. Any term of this Agreement may be amended
and the performance of any term of this Agreement may be waived (either
generally or in a particular instance and

                                      -14-
<PAGE>

either retroactively or prospectively) only with the written consent of the
Company and Purchaser. Any amendment or waiver effected in accordance with this
paragraph shall be binding upon each holder of any securities purchased under
this Agreement at the time outstanding (including securities into which such
securities are convertible), each future holder of all such securities and the
Company.

            8.9 Severability. If one or more provisions of this Agreement are
held to be unenforceable under applicable law, such provision shall be excluded
from this Agreement and the balance of the Agreement shall be interpreted as if
such provision were so excluded and shall be enforceable in accordance with its
terms.

            8.10 Aggregation of Stock. All shares of the Series A Preferred
Stock held or acquired (or Common Stock issued upon conversion thereof) by
affiliated entities or persons (including partners or constituent members and
former partners and former constituent members) shall be aggregated for the
purpose of determining the availability of or discharge of any rights under this
Agreement. For purposes of this Section 8.10, the Company may rely on such
person whom a group of related persons shall designate from time to time for
information relating to the affiliations of entities or persons.

            8.11 GAAP. Where any accounting determination or calculation is
required to be made under this Agreement or the exhibits hereto, such
determination or calculation (unless otherwise provided) shall be made in
accordance with GAAP.

            8.12 Entire Agreement. This Agreement and the documents referred to
herein constitute the entire agreement among the parties and supersede all prior
agreements and understandings, both written and oral, among the parties with
respect to the subject matter hereof and thereof, and no party shall be liable
or bound to any other party in any manner by any warranties, representations, or
covenants except as specifically set forth herein or therein.

                  [Remainder of page intentionally left blank.]

                                      -15-
<PAGE>

         IN WITNESS WHEREOF, the parties have executed this Series B Preferred
Stock Purchase Agreement as of the date first above written.

                                 eResearchTechnology, Inc.

                                 By: /s/ Joel Morganroth
                                     ----------------------------------------
                                     Joel Morganroth, M.D.
                                     Chairman

                                 Address:     30 South 17th Street
                                              Philadelphia, PA 19103

                                 PURCHASER:

                                 Communicade Inc.

                                 By: /s/ Gerard A. Neumann
                                     ----------------------------------------
                                 Name:  Gerard A. Neumann
                                 Title:

                                 Address:     437 Madison Avenue
                                              New York, NY 10022

                                 PARENT:

                                 Premier Research Worldwide, Ltd.

                                 By: /s/ Joel Morganroth
                                     ----------------------------------------
                                     Joel Morganroth, M.D.
                                     Chairman and Chief Executive Officer

                                 Address:     30 South 17th Street
                                              Philadelphia, PA 19103

         [Signature Page to Series A Preferred Stock Purchase Agreement]

<PAGE>

                                    Exhibit A

                           CERTIFICATE OF DESIGNATION

<PAGE>

                                    Exhibit B

                            eResearchTechnology, Inc.

                             SCHEDULE OF EXCEPTIONS

<PAGE>

                                    Exhibit C

                            INVESTOR RIGHTS AGREEMENT

<PAGE>

                                    EXHIBIT D

                                WARRANT AGREEMENT

<PAGE>

                                    EXHIBIT E

                                OPTION AGREEMENT

<PAGE>

                                    EXHIBIT F

                    OPINION OF DUANE, MORRIS & HECKSCHER LLP

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00005-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00005-of-00352.parquet"}]]